TWA
AGIO icon

TCI Wealth Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

TCI Wealth Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-137
Closed -$3.15K – 252
2023
Q1 		$3.15K Buy
137
+21
+18% +$558 ﹤0.01% 1832
2022
Q4 		$3.26K Buy
116
+115
+11,500% +$3.24K ﹤0.01% 1816
2022
Q3 		$0 Buy
+1
New +$27 ﹤0.01% 2228
2022
Q2 		– Sell
-193
Closed -$6K – 2253
2022
Q1 		$6K Hold
193
– – ﹤0.01% 1383
2021
Q4 		$6K Buy
+193
New +$7.77K ﹤0.01% 1492
2021
Q3 		– Sell
-44
Closed -$2K – 2364
2021
Q2 		$2K Buy
+44
New +$2.46K ﹤0.01% 1936
2021
Q1 		– Sell
-20
Closed -$1K – 2157
2020
Q4 		$1K Buy
20
+2
+11% +$79 ﹤0.01% 1317
2020
Q3 		$1K Sell
18
-15
-45% -$657 ﹤0.01% 1243
2020
Q2 		$2K Buy
33
+17
+106% +$787 ﹤0.01% 1016
2020
Q1 		$1K Buy
+16
New +$739 ﹤0.01% 1169
2019
Q2 		– Sell
-13
Closed -$1K – 1403
2019
Q1 		$1K Buy
+13
New +$757 ﹤0.01% 1137
2018
Q4 		– Sell
-1
Closed – – 1426
2018
Q3 		$0 Sell
1
-6
-86% -$483 ﹤0.01% 1454
2018
Q2 		$1K Buy
+7
New +$610 ﹤0.01% 1227

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TCI Wealth Advisors's AGIO Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Agios Pharmaceuticals (AGIO) in Q2 2023, closing a stake of 137 shares — an estimated $3.15K sold.

TCI Wealth Advisors first reported a position in AGIO in Q2 2018 and held it in 13 quarters. The position peaked at $6K in Q1 2022. 153 funds tracked by Wall St. Rank hold AGIO as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Agios Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 137 Agios Pharmaceuticals shares in Q2 2023, an estimated $3.15K.
  • TCI Wealth Advisors first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 13 quarters.
  • TCI Wealth Advisors's Agios Pharmaceuticals position peaked at $6K in Q1 2022.
  • 153 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.